Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2016

01-04-2016 | Epidemiology

Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer

Authors: B. Cabarrou, L. Belin, S. M. Somda, M. C. Falcou, J. Y. Pierga, Y. Kirova, J. P. Delord, B. Asselain, T. Filleron

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Abstract

Use of parametric statistical models can be a solution to reduce the follow-up period time required to estimate long-term survival. Mould and Boag were the first to use the lognormal model. Competing risks methodology seems more suitable when a particular event type is of interest than classical survival analysis. The objective was to evaluate the ability of the Jeong and Fine model to predict long-term cumulative incidence. Survival data recorded by Institut Curie (Paris) from 4761 breast cancer patients treated and followed between 1981 and 2013 were used. Long-term cumulative incidence rates predicted by the model using short-term follow-up data were compared to non-parametric estimation using complete follow-up data. 20- or 25-year cumulative incidence rates for loco-regional recurrence and distant metastasis predicted by the model using a maximum of 10 years of follow-up data had a maximum difference of around 6 % compared to non-parametric estimation. Prediction rates were underestimated for the third and composite event (contralateral or second cancer or death). Predictive ability of Jeong and Fine model on breast cancer data was generally good considering the short follow-up period time used for the estimation especially when a proportion of patient did not experience loco-regional recurrence or distant metastasis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef
2.
go back to reference Pocock SJ, Clayton TC, Altman DG (2002) Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359(9318):1686–1689CrossRefPubMed Pocock SJ, Clayton TC, Altman DG (2002) Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359(9318):1686–1689CrossRefPubMed
3.
go back to reference Boag JW (1949) Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc Ser B Methodol 11(1):15–53 Boag JW (1949) Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc Ser B Methodol 11(1):15–53
4.
go back to reference Mould RF, Boag JW (1975) A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri. Br J Cancer 32(5):529–550CrossRefPubMedPubMedCentral Mould RF, Boag JW (1975) A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri. Br J Cancer 32(5):529–550CrossRefPubMedPubMedCentral
5.
go back to reference Mould RF, Lederman M, Tai P, Wong JKM (2002) Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models. Phys Med Biol 47(22):3893CrossRefPubMed Mould RF, Lederman M, Tai P, Wong JKM (2002) Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models. Phys Med Biol 47(22):3893CrossRefPubMed
6.
go back to reference Tai P, Yu E, Shiels R, Pacella J, Jones K, Sadikov E, Mahmood S (2005) Short-and long-term cause-specific survival of patients with inflammatory breast cancer. BMC Cancer 5(1):137CrossRefPubMedPubMedCentral Tai P, Yu E, Shiels R, Pacella J, Jones K, Sadikov E, Mahmood S (2005) Short-and long-term cause-specific survival of patients with inflammatory breast cancer. BMC Cancer 5(1):137CrossRefPubMedPubMedCentral
7.
go back to reference Kalbfleisch JD, Prentice RL (2011) The statistical analysis of failure time data, vol 360. Wiley, Hoboken Kalbfleisch JD, Prentice RL (2011) The statistical analysis of failure time data, vol 360. Wiley, Hoboken
8.
go back to reference Jeong J-H, Fine J (2006) Direct parametric inference for the cumulative incidence function. J R Stat Soc Ser C Appl Stat 55(2):187–200CrossRef Jeong J-H, Fine J (2006) Direct parametric inference for the cumulative incidence function. J R Stat Soc Ser C Appl Stat 55(2):187–200CrossRef
9.
go back to reference Gooley TA, Leisenring W, Crowley J, Storer BE et al (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706CrossRefPubMed Gooley TA, Leisenring W, Crowley J, Storer BE et al (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706CrossRefPubMed
10.
go back to reference Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer. Cancer 106(1):35–41CrossRefPubMed Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer. Cancer 106(1):35–41CrossRefPubMed
11.
go back to reference Choudhury JB (2002) Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 21(8):1129–1144CrossRefPubMed Choudhury JB (2002) Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 21(8):1129–1144CrossRefPubMed
12.
go back to reference Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14(10):2738–2746PubMed Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14(10):2738–2746PubMed
14.
go back to reference Shi H, Cheng Y, Jeong J-H (2013) Constrained parametric model for simultaneous inference of two cumulative incidence functions. Biom J 55(1):82–96CrossRefPubMed Shi H, Cheng Y, Jeong J-H (2013) Constrained parametric model for simultaneous inference of two cumulative incidence functions. Biom J 55(1):82–96CrossRefPubMed
15.
go back to reference Moreno-Betancur M, Rey G, Latouche A (2015) Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure. Biometrics 71(2):498–507CrossRefPubMed Moreno-Betancur M, Rey G, Latouche A (2015) Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure. Biometrics 71(2):498–507CrossRefPubMed
16.
go back to reference Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273–1283CrossRefPubMedPubMedCentral Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273–1283CrossRefPubMedPubMedCentral
17.
go back to reference Sy JP, Taylor JM (2000) Estimation in a Cox proportional hazards cure model. Biometrics 56(1):227–236CrossRefPubMed Sy JP, Taylor JM (2000) Estimation in a Cox proportional hazards cure model. Biometrics 56(1):227–236CrossRefPubMed
18.
go back to reference Andersson TM, Dickman PW, Eloranta S, Lambert PC (2011) Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol 11(1):96CrossRefPubMedPubMedCentral Andersson TM, Dickman PW, Eloranta S, Lambert PC (2011) Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol 11(1):96CrossRefPubMedPubMedCentral
19.
go back to reference Choi KC, Zhou X (2002) Large sample properties of mixture models with covariates for competing risks. J Multivar Anal 82(2):331–366CrossRef Choi KC, Zhou X (2002) Large sample properties of mixture models with covariates for competing risks. J Multivar Anal 82(2):331–366CrossRef
20.
go back to reference Nicolaie MA, van Houwelingen HC, Putter H (2010) Vertical modeling: a pattern mixture approach for competing risks modeling. Stat Med 29(11):1190–1205PubMed Nicolaie MA, van Houwelingen HC, Putter H (2010) Vertical modeling: a pattern mixture approach for competing risks modeling. Stat Med 29(11):1190–1205PubMed
Metadata
Title
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer
Authors
B. Cabarrou
L. Belin
S. M. Somda
M. C. Falcou
J. Y. Pierga
Y. Kirova
J. P. Delord
B. Asselain
T. Filleron
Publication date
01-04-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3789-9

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine